BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 1827422)

  • 1. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.
    Arrigo SJ; Chen IS
    Genes Dev; 1991 May; 5(5):808-19. PubMed ID: 1827422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing.
    Schwartz S; Felber BK; Pavlakis GN
    Virology; 1991 Aug; 183(2):677-86. PubMed ID: 1830183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products.
    Garrett ED; Tiley LS; Cullen BR
    J Virol; 1991 Mar; 65(3):1653-7. PubMed ID: 1825343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.
    D'Agostino DM; Felber BK; Harrison JE; Pavlakis GN
    Mol Cell Biol; 1992 Mar; 12(3):1375-86. PubMed ID: 1545819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.
    Arrigo SJ; Weitsman S; Rosenblatt JD; Chen IS
    J Virol; 1989 Nov; 63(11):4875-81. PubMed ID: 2677405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rev-dependent expression of three species of HIV-1 mRNAs (review).
    Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
    Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vpr is preferentially targeted by CTL during HIV-1 infection.
    Altfeld M; Addo MM; Eldridge RL; Yu XG; Thomas S; Khatri A; Strick D; Phillips MN; Cohen GB; Islam SA; Kalams SA; Brander C; Goulder PJ; Rosenberg ES; Walker BD;
    J Immunol; 2001 Sep; 167(5):2743-52. PubMed ID: 11509618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Codon-optimized reading frames facilitate high-level expression of the HIV-1 minor proteins.
    Anson DS; Dunning KR
    Mol Biotechnol; 2005 Sep; 31(1):85-8. PubMed ID: 16118417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the HIV type 1 subtype C accessory genes vif, vpr, and vpu.
    Bell CM; Connell BJ; Capovilla A; Venter WD; Stevens WS; Papathanasopoulos MA
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):322-30. PubMed ID: 17331040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.
    Rossenkhan R; Novitsky V; Sebunya TK; Musonda R; Gashe BA; Essex M
    PLoS One; 2012; 7(5):e35491. PubMed ID: 22590503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.
    Kraus MH; Parrish NF; Shaw KS; Decker JM; Keele BF; Salazar-Gonzalez JF; Grayson T; McPherson DT; Ping LH; Anderson JA; Swanstrom R; Williamson C; Shaw GM; Hahn BH
    Virology; 2010 Feb; 397(2):346-57. PubMed ID: 20003995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
    Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
    Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?
    Bour S; Schubert U; Peden K; Strebel K
    J Virol; 1996 Feb; 70(2):820-9. PubMed ID: 8551620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains.
    Bibollet-Ruche F; Loussert-Ajaka I; Simon F; Mboup S; Ngole EM; Saman E; Delaporte E; Peeters M
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):951-61. PubMed ID: 9686641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
    Aldrovandi GM; Zack JA
    J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication.
    Kuwata T; Igarashi T; Ido E; Jin M; Mizuno A; Chen J; Hayami M
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2181-91. PubMed ID: 7561755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.